Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

FDA confirms Adderall shortage in the US

Por: ABC7 World October 13, 2022

thumbnail

of the immediate release formulation of amphetamine mixed salts, commonly referred to by the brand name Adderall.Adderall is a stimulant medication that can treat ADHD. It requires a prescription and as a controlled substance, supply is strictly monitored, and distribution is limited.Some individuals already knew there was a problem having reported going weeks without medication and calling multiple pharmacies to fill prescriptions. Some... + full article



Similar News

FDA confirms Adderall shortage in the US

ABC News USA Health October 13, 2022

thumbnailAfter weeks of individual reports of frustration with getting Adderall prescriptions filled, the Food and Drug Administration confirmed Wednesday a of the immediate release formulation of amphetamine mixed salts, commonly referred to by the brand name Adderall.Adderall is a... + más

Did COVID-19 pandemic contribute to Adderall shortage? | ABC News

Did COVID-19 pandemic contribute to Adderall shortage? | ABC7


Adderall shortages impacting ADHD patients

Fox Business USA Business October 07, 2022

thumbnailCheck out what's clicking on FoxBusiness.com Widespread shortages of Adderall and other versions of the drug used for treating attention-deficit hyperactivity disorder (ADHD) are deepening in the U.S., causing desperation in patients who rely on the medication to focus. The... + más

For Some Women With ADHD, TikTok Is the First Place They Felt Heard | Time

The DEA is investigating Done over ADHD drug prescriptions | The Verge


ALS drug wins FDA approval despite questionable data

ABC News USA Health September 30, 2022

thumbnailWASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | WPLG Local 10


ALS drug wins FDA approval despite questionable data

WPLG Local 10 USA Politics September 30, 2022

thumbnailWASHINGTON – A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | ABC News


FDA concedes delays in response to baby formula shortage

WPLG Local 10 USA Health September 24, 2022

thumbnailWASHINGTON – The Food and Drug Administration acknowledged Tuesday that its response to the U.S. was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency offers its first formal... + más

FDA concedes delays in response to baby formula shortage | ABC News

‘If the FDA is expected to do more, it needs more’: FDA investigation into baby-formula crisis points to its own shortcomings. But shortages persist. | MarketWatch


FDA concedes delays in response to baby formula shortage

ABC News USA Health September 21, 2022

thumbnailWASHINGTON -- The Food and Drug Administration acknowledged Tuesday that its response to the U.S. infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency... + más

FDA concedes delays in response to baby formula shortage | Associated Press

Internal FDA report on infant formula crisis details shortfalls in response | ABC News


FDA concedes delays in response to baby formula shortage

Associated Press USA Politics September 21, 2022

thumbnailWASHINGTON (AP) — The Food and Drug Administration acknowledged Tuesday that its response to the U.S. was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency offers its first... + más

FDA concedes delays in response to baby formula shortage | ABC News

Internal FDA report on infant formula crisis details shortfalls in response | ABC News



About iurex | Privacy Policy | Disclaimer |